NASDAQ
Tandem Diabetes Care, Inc. (TNDM)
♥ 518 Thanks from members
Tandem Diabetes Care (TNDM) reported Q2 2026 sales of $254.6 million and a narrowed net loss, reaffirming full-year guidance of $1.07B–$1.09B. Despite a slight revenue consensus miss, strong pump shipments, improving gross margins (57%), and strategic pharmacy-channel distribution drove positive market reactions.